Introduction
While the United States boasts of an advanced medical technology, several statistics indicate challenges in American health. A Common Wealth report shows the U.S has the lowest life expectancy at birth, the highest death rates for avoidable or treatable conditions, the highest maternal and infant mortality, and among the highest suicide rates. The U.S. has the highest rate of people with multiple chronic conditions and an obesity rate nearly twice the OECD average which begs the question; are medical doctors missing out on important updates on how to treat diseases?
How Doctors may be missing important links between health and diseases
While people are experiencing positive results with plant-based medicines, many doctors lag behind in acknowledging their efficacy. This gap may stem from medical school curricula, which often overlook plant-based medicine. Traditional medical education tends to prioritize pharmaceutical interventions over holistic approaches. As a result, healthcare providers may lack training and awareness regarding the potential benefits of plant-based therapies.
One crucial but often overlooked aspect of plant-based medicine and its potential to improve health lies in the endocannabinoid system (ECS). The ECS is a complex network of receptors, enzymes, and endocannabinoids spread throughout the body, regulating various physiological processes such as mood, appetite, pain perception, and immune response. It is described as the master switch that keeps your body functioning. Despite its significance, many healthcare professionals are not adequately informed about the ECS and its functions. Medical schools are not teaching about the ECS.
The knowledge gap regarding the endocannabinoid system (ECS) is contributing to a decline in healthcare, especially as hemp-based medicine demonstrates benefits for various conditions. With limited understanding of the ECS among healthcare professionals, opportunities to leverage plant-based cannabinoids like CBD for therapeutic purposes are often overlooked or underutilized.
Several research studies including those reported by the FDA have identified the possible use of hemp-based compounds like CBD for several disease conditions. Hemp offers numerous potential benefits due to its interaction with the endocannabinoid system (ECS). Cannabinoids like CBDa found in hemp can empower ECS activity, influencing functions such as mood, pain perception, inflammation, and immune response. You can read about the ECS on Nesas Hemp.
This interaction underlies hemp’s therapeutic effects, including pain relief, stress reduction, anti-inflammatory properties, and potential neuroprotective effects. Additionally, hemp-derived cannabinoids may promote relaxation, improve sleep quality, and support overall well-being. By targeting the ECS, genuine hemp-based products have the potential to address a wide range of health concerns, offering natural alternatives for various conditions and promoting holistic wellness.
When doctors fully acknowledge the ECS, it could revolutionize healthcare. With a deeper understanding of how the ECS regulates key physiological processes, healthcare providers can tailor treatment approaches to target ECS dysregulation. This may lead to more personalized and effective therapies for a wide range of conditions, including chronic pain, inflammation, mood disorders, and neurological conditions.
Conclusion
While hemp may hold the key to empowering the endocannabinoid system and improving disease outcomes, the CBD industry is not fully regulated. The non-regulated nature of the industry has given room to the existence of several poor quality products which may worsen the health of users. According to a report published byStatista, over 28% of CBD products are not tested for pesticides and other possible contaminants. This negligence can cause side effects and deaths in severe cases. Although this may sound scary, there is no need to panic as there are genuine products that are fully organic certified and each batch is tested by an FDA approved laboratory to prove quality and safety. These companies prioritize third-party testing from an FDA-approved laboratory to ensure CBD products are free from heavy metals, mold, bacteria and pesticides to ensure safety of consumers.